---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-22-000090"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T11:45:47.115335+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints Dr. Anna Loengard to Board of Directors

## Summary
- Anna Loengard, M.D. appointed as Class I director effective November 28, 2022.
- She will receive a pro-rata annual retainer and a pro-rated RSU award valued at $200,000.
- Previously served as CMO of AccentCare, Caravan Health, and Queen's Healthcare System.
- Her geriatric medicine and value-based care expertise supports Clover's in-home primary care strategy.

## SEC filing metadata
- accession: 0001801170-22-000090
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/0001801170-22-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/clov-20221128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-22-000090
- JSON: https://secwatch.observer/filing/0001801170-22-000090.json
- Plain text: https://secwatch.observer/filing/0001801170-22-000090.txt

## Key facts
- Executive change
  Anna Loengard, M.D. was appointed as Class I director at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Class I director
  source text: On November 28, 2022, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Anna Loengard, M.D., to serve as a Class I director of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/0001801170-22-000090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.